New Hampshire Priority Topic Investments
Click on any of the tabs below to learn more about each topic.
New Hampshire Overdose Investment Snapshot
Combatting the current overdose crisis is a priority for the agency. This page provides an overview of the FY21 CDC Injury Center (NCIPC) overdose investments for the state of New Hampshire.
There were 91,799 drug overdose deaths in the United States in 2020 (28.3 deaths per 100,000 standard population), a stark 30% increase from 2019. Approximately 75% of drug overdose deaths in 2020 involved an opioid, with synthetic opioids (e.g., illicitly manufactured fentanyls) accounting for more than 80% of all opioid-involved deaths. Drug overdose deaths involving synthetic opioids increased by 55% and deaths involving psychostimulants (e.g., methamphetamine) increased by 47% from 2019 to 2020. Drug overdose deaths involving cocaine also increased by 22%.
In 2020 in New Hampshire there were:
overdose deaths per 100,000 people (age-adjusted)
Source: NVSS – Drug Overdose Deaths
Overdose Data to Action (OD2A)
Public Health and Public Safety
*average award amount
Examples of How New Hampshire Is Working to Prevent Overdose
Pharmacy harm reduction
New Hampshire identified pharmacies without standing orders for naloxone and gave them targeted information on how to enact the statewide standing order, which allows pharmacies to dispense naloxone without a prescription, increasing access to naloxone in pharmacies.
New Hampshire improved real-time surveillance of emerging drug trends and overdose hotspots by collaborating with private labs to conduct comprehensive toxicology testing on suspected overdose substances.
CDC Overdose Prevention Strategies
CDC’s Injury Center plays a critical role in addressing the drug overdose epidemic by driving progress in the five strategic priorities that guide CDC’s response framework for preventing overdoses.